Skip to content

Profound Medical PROF Deferred Tax Assets

Deferred Tax Assets at other companies

Bioventus logo
BioventusBVS
$5.52M+16.4%
Intuitive Surgical logo
Intuitive SurgicalISRG
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$5.3M+104%
Gross profit$3.8M+107%
Operating income-$8.0M+28.2%
Net income-$7.1M+34.2%
EPS (diluted)$0.19-47.2%

Balance sheet

See full
Cash & equivalents$50.3M+8.3%
Total debt$7.5M+52.8%
Total equity$59.4M+17.0%
Total assets$73.5M+20.7%

Cash flow

See full
Operating cash flow-$8.6M-3.6%
CapEx$44.0K
Free cash flow-$9.6M

Valuation

See full
Market cap$241.65M+30.7%
Enterprise value$198.81M+28.7%
P/S12.8×-2.8×

Profitability

See full
Gross margin71.1%+3.4pp
Operating margin-202.6%-51.3pp
Net margin-206.8%-39.0pp
FCF margin-238.4%

Returns & leverage

See full
Return on equity-70.6%+4.8pp
Debt / equity0.1×0.0×
Current ratio6.6×-4.8×

Where this comes from

Reported directly by Profound Medical in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Profound Medical's deferred tax assets?
Profound Medical (PROF) reported deferred tax assets of $68K in Q1 2026.
How has Profound Medical's deferred tax assets changed year-over-year?
Profound Medical's deferred tax assets decreased by 21.8% year-over-year, from $87K to $68K.
What does deferred tax assets mean?
Represents future tax benefits arising from temporary differences between the book value of assets/liabilities and their tax basis, or from carry-forward tax losses. These assets are realized when the firm generates sufficient taxable income to offset these differences. It serves as an indicator of future tax savings potential.